Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × Triptorelin Pamoate × Clear all

Status

Sponsor Class

OTHER 1 INDUSTRY 1 FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 31 Polycystic Ovary Syndrome 9 Breast Neoplasms 8 Infertility 7 Ovarian Hyperstimulation Syndrome 3 Lymphoma 3 Sarcoma, Ewing 2 Sarcoma 2 Prostate Adenocarcinoma 2 Osteosarcoma 2 Neoplasms 2 Uterine Anomalies 1 The Neoadjuvant Therapy 1 Salpingitis 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Myofibroma 1 Metabolic Syndrome 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Helping Behavior 1 Fatty Liver 1 Endometritis 1 Endometriosis 1 Drug-Related Side Effects and Adverse Reactions 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1

Interventions

Radiosurgery 79 Capecitabine 77 Oxaliplatin 74 Fluorouracil 69 Bevacizumab 69 Gemcitabine 67 Leucovorin 61 pembrolizumab 53 Nivolumab 52 Paclitaxel 48 Irinotecan 47 Radiotherapy 45 Cisplatin 44 Everolimus 38 Drug Therapy 36 Docetaxel 36 Magnetic Resonance Spectroscopy 35 Cyclophosphamide 35 Cetuximab 35 Ipilimumab 32 Carboplatin 32 Trastuzumab 31 Sunitinib 30 Sorafenib 26 Erlotinib Hydrochloride 25 Doxorubicin 23 Surveys and Questionnaires 20 Surgical Procedures, Operative 20 Biopsy 19 Temozolomide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06473259 2024-06-25

ECHOS

Santa Chiara Hospital

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡